Harary Paul M, Hori Yusuke S, Kassu Rodas, Persad Amit R L, Tayag Armine, Ustrzynski Louisa, Emrich Sara C, Gibbs Iris C, Park David J, Chang Steven D, Fernandez-Miranda Juan C
Department of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
J Neurosurg Case Lessons. 2025 May 5;9(18). doi: 10.3171/CASE24849.
Malignant transformation of an intracranial epidermoid cyst (EC) into squamous cell carcinoma (SCC) is an exceedingly rare occurrence that is typically diagnosed on postoperative histology. The mechanisms underlying transformation remain poorly understood, with limited characterization of genetic changes associated with progression.
A 55-year-old female presented with a large cerebellopontine angle EC with an enhancing nodule in the left tectum, for which she underwent resection. Three months following surgery, rapid enlargement of the residual tectal component required reoperation, with pathology showing SCC. Paired next-generation sequencing of the EC and SCC revealed multiple shared variants, including a pathogenic TP53 mutation. Additionally, the SCC contained a pathogenic PTEN variant absent in the EC, suggesting a second driver mutation contributing to malignant transformation of an EC (MTEC). Her SCC was resistant to volumetric modulated arc therapy, requiring subsequent chemotherapy and pembrolizumab combined with stereotactic radiosurgery. Despite a favorable initial response, she died 26 months following MTEC diagnosis.
To the authors' knowledge, this represents the first use of paired molecular profiling to link intracranial SCC to an EC precursor, enhancing precision of this rare diagnosis. Additionally, this case identifies specific genetic alterations associated with transformation, providing insight into the largely unknown mechanisms underlying MTEC. https://thejns.org/doi/10.3171/CASE24849.
颅内表皮样囊肿(EC)恶变成为鳞状细胞癌(SCC)极为罕见,通常在术后组织学检查时确诊。恶变的潜在机制仍知之甚少,与进展相关的基因变化特征有限。
一名55岁女性因左侧顶盖有强化结节的巨大桥小脑角EC就诊,接受了切除术。术后三个月,残余顶盖部分迅速增大,需要再次手术,病理显示为SCC。对EC和SCC进行配对的二代测序发现了多个共同变异,包括一个致病性TP53突变。此外,SCC中含有一个EC中不存在的致病性PTEN变异,提示这是导致EC恶变(MTEC)的第二个驱动突变。她的SCC对容积调强弧形放疗耐药,需要后续化疗以及帕博利珠单抗联合立体定向放射外科治疗。尽管最初反应良好,但她在MTEC诊断后26个月死亡。
据作者所知,这是首次使用配对分子分析将颅内SCC与EC前体联系起来,提高了这种罕见诊断的准确性。此外,该病例确定了与恶变相关的特定基因改变,为MTEC背后 largely unknown 的机制提供了见解。https://thejns.org/doi/10.3171/CASE24849 。